GPP
CINC

Great Point Partners’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Great Point Partners’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,019,153
Closed -$12.5M – 58
2022
Q4 		$12.5M Buy
1,019,153
+717,829
+238% +$17.1M 2.46% 16
2022
Q3 		$9.89M Sell
301,324
-367,876
-55% -$10.4M 2.38% 17
2022
Q2 		$12.6M Buy
669,200
+589,530
+740% +$11.3M 3.02% 14
2022
Q1 		$1.4M Buy
+79,670
New +$1.63M 0.34% 27

Great Point Partners's CINC Position: Q1 2023 in Review

Great Point Partners sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 1,019,153 shares — an estimated $12.5M sold.

Great Point Partners first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $12.6M in Q2 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • Great Point Partners reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Great Point Partners sold 1,019,153 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $12.5M.
  • Great Point Partners first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
  • Great Point Partners's CinCor Pharma, Inc. Common Stock position peaked at $12.6M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Great Point Partners's 13F filing for Q1 2023, filed 15 May 2023.